RB1 and TP53 inactivation have been reported as markers of transformation from lung adenocarcinoma with EGFR mutation, ROS1 fusion, and ALK rearrangement to SCLC (12, 18–21). This evidence concerns the gene TP53 and small cell lung carcinoma.